Ildong Holdings's latest marketcap:
As of 07/05/2025, Ildong Holdings's market capitalization has reached $60.34 M. According to our data, Ildong Holdings is the 28341th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 60.34 M |
| Revenue (ttm) | 469.91 M |
| Net Income (ttm) | 46.88 M |
| Shares Out | 11.29 M |
| EPS (ttm) | 3.76 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2025 |
Ildong Holdings's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | ₩60.34 M | -8.72% | 28341 |
| 12/30/2024 | ₩91.92 B | -22.62% | 26544 |
| 12/28/2023 | ₩118.79 B | -47.79% | 23674 |
| 12/29/2022 | ₩227.54 B | 36.15% | 18663 |
| 12/30/2021 | ₩167.12 B | 6.86% | 20956 |
| 12/30/2020 | ₩156.4 B | 30.99% | 18511 |
| 12/30/2019 | ₩119.39 B | -15.6% | 17977 |
| 12/28/2018 | ₩141.47 B | -8.86% | 16124 |
| 12/28/2017 | ₩155.22 B | -13.78% | 16141 |
| 12/29/2016 | ₩180.04 B | -70.52% | 14132 |
Company Profile
Company Overview
Ildong Holdings Co., Ltd. is a South Korean pharmaceutical company engaged in the development, manufacturing, and supply of healthcare products. Founded in 1941 and headquartered in Seoul, the company operates both domestically and internationally.
Core Business Activities
- Pharmaceutical Development: Focuses on new drugs targeting resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing.
- Health Supplements: Produces raw vitamins, probiotics (including Biovita lactobacillus), and multivitamin products like Aronamin.
- Health Foods & Ingredients: Researches and manufactures health foods, including hyaluronic acid for drugs, medical devices, and cosmetics.
- Medical Distribution: Supplies medical devices, quasi-drugs, health supplements, food, beverages, and cosmetics via online platforms.
- Prescription Drugs: Manufactures both original and generic prescription medications.
Additional Services
- Probiotics production and distribution.
- Pharmaceutical SI consulting, system development, RFID/barcode solutions.
- Advertising and marketing services.
Corporate History
Formerly known as Ildong Pharmaceutical Co., Ltd., the company rebranded to Ildong Holdings Co., Ltd. in August 2016.
Frequently Asked Questions
-
What is Ildong Holdings's (KRX-000230) current market cap?As of 07/05/2025, Ildong Holdings (including the parent company, if applicable) has an estimated market capitalization of $60.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ildong Holdings (KRX-000230) rank globally by market cap?Ildong Holdings global market capitalization ranking is approximately 28341 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.